Viewing Study NCT01545804


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-08 @ 3:26 PM
Study NCT ID: NCT01545804
Status: COMPLETED
Last Update Posted: 2017-02-09
First Post: 2012-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
Sponsor: National Taiwan University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular carcinoma View